News

On Dec. 10, first-year Weill Cornell Medical College students memorialized the 28 people who generously donated their bodies to the institution’s Gross Anatomy program.

Awards, honors and achievements for the month of December. 

A new study from Weill Cornell Medicine uncovers how a viral protein called E4ORF1 precisely activates a specific signaling complex in human blood vessel cells to support cell survival. 

Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits from coronary artery bypass grafting compared with percutaneous coronary intervention, also known as stenting, according to a large study by Weill Cornell Medicine investigators.

Weill Cornell Medicine is poised to thrive in the coming years, with a planned expansion of its clinical enterprise serving as an engine for overall institutional growth, Dean Robert Harrington conveyed Dec. 16 during his biannual State of Weill Cornell Medicine address.

From light-activated pain relief to next-generation cancer immunotherapies, scientists and clinicians showcased bold ideas for translating lab discoveries into real-world treatments as part of the Accelerating BioVenture Innovation (ABI) program within Enterprise Innovation at Weill Cornell.

Dr. John Blenis's lab discovered that low levels of folate, a B vitamin essential for cell growth, can trigger specific genetic changes found in lung tumors, establishing a link between nutrition and cancer, which may open new dietary approaches for prevention and treatment.

People who felt lonely before having a heart attack were significantly more likely to end up back in the hospital within a month of discharge, according to findings from researchers in the Division of General Internal Medicine at Weill Cornell Medicine. 

Gut microbes may play a key role in training a mother’s immune system to adapt to the developing fetus during pregnancy, according to a preclinical study by Weill Cornell Medicine investigators.

While many women assume pelvic floor health issues are simply their fate—part of having vaginal deliveries, getting older, gaining weight or entering menopause, they are not a part of normal aging. Dr. Larissa Rodríguez is working to change perceptions of this disorder, which affects one-in-three women in her lifetime.

Three minutes and one slide were all it took for twelve young scientists to turn cutting-edge research into dramatic stories of hope at Weill Cornell Medicine’s tenth annual Three-Minute Thesis (3MT) competition on Nov. 13 in Uris Auditorium.

Dopamine neurons in a part of the brain called the midbrain may, with aging, be increasingly susceptible to a vicious spiral of decline driven by fuel shortages, according to a study led by Weill Cornell Medicine investigators.

Weill Cornell Medicine’s Ninth Annual Dean’s Symposium on Innovation and Entrepreneurship celebrated and fostered the entrepreneurial spirit on Nov. 17 at Weill Cornell's Griffis Faculty Club.

More than 75 employees were honored at the President’s Awards for Employee Excellence, representing Cornell’s Ithaca campus as well as Weill Cornell Medicine and Weill Cornell Medicine-Qatar. This year marked the first time nominations were open to all three campuses.

Dr. Hazel Szeto's discovery of a first-in-class compound that had mitochondrial therapeutic potential is now a U.S. Food and Drug Administration-approved drug.

Dr. Despina Siolas, assistant professor of medicine at Weill Cornell Medicine, is working to personalize treatment for pancreatic cancer and develop new therapeutic regimens that save more patient lives.

Awards, honors and achievements for the month of November.

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by Weill Cornell Medicine investigators.

The roots of addiction risk may lie in how young brains function long before substance use begins, according to a new study from Weill Cornell Medicine.

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why many cancer patients experience debilitating pain as a side effect, according to a new study by Weill Cornell Medicine and Wake Forest University School of Medicine researchers.